These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Intracervical application of prostaglandin F2 alpha gel as low risk method of cervical dilatation for therapeutic abortion (author's transl)].
    Author: Fritzsche H, Seewald HJ, Voigt R.
    Journal: Geburtshilfe Frauenheilkd; 1981 Mar; 41(3):237-8. PubMed ID: 7215769.
    Abstract:
    In cases of interruption prostaglandin F2 alpha gel is applied intracervically and leads to dilatation of the cervix without any damage. This form of the therapy can be recommended because of its good results and harmless side effects. Prostaglandin F2 alpha gel was applied intracervically to induce cervical dilatation in 328 cases of induced abortion. The subjects were 15-27 years of age and nulliparae. In 59.8% of the cases, a complete or incomplete abortion occurred within 12-15 hours of the infusion. In 37.2% of the cases, the cervix had dilatated to the point that no mechanical dilatation was necessary to perform an induced abortion. The procedure failed in 7 cases. The only serious side effects were 4 cases of serious bleeding after incomplete abortion and 1 case of atonic bleeding after the curettage.
    [Abstract] [Full Text] [Related] [New Search]